193 related articles for article (PubMed ID: 31009625)
1. Synergistic effects of 7-O-geranylquercetin and siRNAs on the treatment of human breast cancer.
Zuo J; Jiang Y; Zhang E; Chen Y; Liang Z; Zhu J; Zhao Y; Xu H; Liu G; Liu J; Wang W; Zhang S; Zhen Y
Life Sci; 2019 Jun; 227():145-152. PubMed ID: 31009625
[TBL] [Abstract][Full Text] [Related]
2. 7-O-geranylquercetin contributes to reverse P-gp-mediated adriamycin resistance in breast cancer.
Zhang E; Liu J; Shi L; Guo X; Liang Z; Zuo J; Xu H; Wang H; Shu X; Huang S; Zhang S; Kang X; Zhen Y
Life Sci; 2019 Dec; 238():116938. PubMed ID: 31593704
[TBL] [Abstract][Full Text] [Related]
3. 7-O-geranylquercetin-induced autophagy contributes to apoptosis via ROS generation in human non-small cell lung cancer cells.
Wang EX; Zou BY; Shi L; Du LY; Zhu YY; Jiang YM; Ma XD; Kang XH; Wang CY; Zhen YH; Sun LD
Life Sci; 2017 Jul; 180():102-113. PubMed ID: 28495516
[TBL] [Abstract][Full Text] [Related]
4. Targeted-delivery of siRNA via a polypeptide-modified liposome for the treatment of gp96 over-expressed breast cancer.
Liang Z; Du L; Zhang E; Zhao Y; Wang W; Ma P; Dai M; Zhao Q; Xu H; Zhang S; Zhen Y
Mater Sci Eng C Mater Biol Appl; 2021 Feb; 121():111847. PubMed ID: 33579510
[TBL] [Abstract][Full Text] [Related]
5. Combination of 7-
Chen Y; Li X; Shi L; Ma P; Wang W; Wu N; Gan Y; Han X; Huang S; Kang X; Liu S; Zhen Y
Aging (Albany NY); 2022 Sep; 14(17):7156-7169. PubMed ID: 36107024
[TBL] [Abstract][Full Text] [Related]
6. Survivin downregulation by siRNA/cationic liposome complex radiosensitises human hepatoma cells in vitro and in vivo.
Yang W; Sun T; Cao J; Liu F
Int J Radiat Biol; 2010 Jun; 86(6):445-57. PubMed ID: 20470195
[TBL] [Abstract][Full Text] [Related]
7. ZIC1 acts a tumor suppressor in breast cancer by targeting survivin.
Han W; Cao F; Gao XJ; Wang HB; Chen F; Cai SJ; Zhang C; Hu YW; Ma J; Gu X; Ding HZ
Int J Oncol; 2018 Sep; 53(3):937-948. PubMed ID: 29956756
[TBL] [Abstract][Full Text] [Related]
8. Combination of survivin siRNA with neoadjuvant chemotherapy enhances apoptosis and reverses drug resistance in breast cancer MCF-7 cells.
Dong H; Yao L; Bi W; Wang F; Song W; Lv Y
J Cancer Res Ther; 2015; 11(4):717-22. PubMed ID: 26881507
[TBL] [Abstract][Full Text] [Related]
9. Survivin knockdown enhances gastric cancer cell sensitivity to radiation and chemotherapy in vitro and in nude mice.
Shen X; Zheng JY; Shi H; Zhang Z; Wang WZ
Am J Med Sci; 2012 Jul; 344(1):52-8. PubMed ID: 22261621
[TBL] [Abstract][Full Text] [Related]
10. Novel Survivin-Targeted Small Interfering RNA Delivered by Nanoparticles.
Feng C; Wang T; Zhang Y; Qu K; Tang S
Am J Med Sci; 2017 Nov; 354(5):506-512. PubMed ID: 29173363
[TBL] [Abstract][Full Text] [Related]
11. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
Hu Y; Xu K; Yagüe E
Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
[TBL] [Abstract][Full Text] [Related]
12. [Effects of RNA interference on epidermal growth factor receptor expression in breast cancer cells: a study in tumor-bearing nude mice].
Wu WD; Fang CH; Yang ZX
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jan; 28(1):60-4. PubMed ID: 18227029
[TBL] [Abstract][Full Text] [Related]
13. Ginkgetin inhibits growth of breast carcinoma via regulating MAPKs pathway.
Cao J; Tong C; Liu Y; Wang J; Ni X; Xiong MM
Biomed Pharmacother; 2017 Dec; 96():450-458. PubMed ID: 29031204
[TBL] [Abstract][Full Text] [Related]
14. Berberine and Evodiamine Act Synergistically Against Human Breast Cancer MCF-7 Cells by Inducing Cell Cycle Arrest and Apoptosis.
Du J; Sun Y; Lu YY; Lau E; Zhao M; Zhou QM; Su SB
Anticancer Res; 2017 Nov; 37(11):6141-6151. PubMed ID: 29061795
[TBL] [Abstract][Full Text] [Related]
15. [Suppressing the growth of Hep-2 human laryngeal cancer cells by silencing survivin gene in vitro and in vivo].
Wen LJ; Gao LF; Ji K; Zhang HJ; Fu DN; Yang JP; Xu YP; Chen GW; Jin CS; Zhao XJ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Aug; 45(8):674-9. PubMed ID: 21055246
[TBL] [Abstract][Full Text] [Related]
16. The flavonoid TL-2-8 induces cell death and immature mitophagy in breast cancer cells via abrogating the function of the AHA1/Hsp90 complex.
Liu HJ; Jiang XX; Guo YZ; Sun FH; Kou XH; Bao Y; Zhang ZQ; Lin ZH; Ding TB; Jiang L; Lei XS; Yang YH
Acta Pharmacol Sin; 2017 Oct; 38(10):1381-1393. PubMed ID: 28504248
[TBL] [Abstract][Full Text] [Related]
17. Recombinant attenuated Salmonella typhimurium carrying a plasmid co-expressing ENDO-VEGI151 and survivin siRNA inhibits the growth of breast cancer in vivo.
Li Z; Yin PH; Yang SS; Li QY; Chang T; Fang L; Shi LX; Fang GE
Mol Med Rep; 2013 Apr; 7(4):1215-22. PubMed ID: 23404494
[TBL] [Abstract][Full Text] [Related]
18. Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus.
Khan Z; Khan AA; Prasad GB; Khan N; Tiwari RP; Bisen PS
Radiother Oncol; 2016 Feb; 118(2):359-68. PubMed ID: 26747757
[TBL] [Abstract][Full Text] [Related]
19. Polyporus umbellatus inhibited tumor cell proliferation and promoted tumor cell apoptosis by down-regulating AKT in breast cancer.
Tan XL; Guo L; Wang GH
Biomed Pharmacother; 2016 Oct; 83():526-535. PubMed ID: 27447121
[TBL] [Abstract][Full Text] [Related]
20. Toxicological exploration of peptide-based cationic liposomes in siRNA delivery.
Zhu Y; Meng Y; Zhao Y; Zhu J; Xu H; Zhang E; Shi L; Du L; Liu G; Zhang C; Xu X; Kang X; Zhen Y; Zhang S
Colloids Surf B Biointerfaces; 2019 Jul; 179():66-76. PubMed ID: 30947085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
